Literature DB >> 29743138

CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab.

Paola Queirolo1, Beatrice Dozin2, Anna Morabito3, Barbara Banelli4, Roberta Carosio3, Vincenzo Fontana2, Pier Francesco Ferrucci5, Chiara Martinoli5, Emilia Cocorocchio5, Paolo A Ascierto6, Gabriele Madonna6, Ester Simeone6, Federica De Galitiis7, Gian Carlo Antonini Cappellini7, Paolo Marchetti8, Michele Guida9, Stefania Tommasi9, Laura Ghilardi10, Barbara Merelli10, Paolo Fava11, Simona Osella-Abate12, Massimo Guidoboni13, Massimo Romani3, Diego Ferone14, Francesco Spagnolo1, Maria Pia Pistillo15.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29743138     DOI： 10.1016/j.ejca.2018.04.005

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  6 in total

1.  Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis.

Authors:  Laura C Cappelli; Mehmet T Dorak; Maria P Bettinotti; Clifton O Bingham; Ami A Shah
Journal:  Rheumatology (Oxford)       Date:  2019-03-01       Impact factor: 7.580

2.  Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors.

Authors:  Sanjay S Shete; Maria E Suarez-Almazor; Noha Abdel-Wahab; Adi Diab; Robert K Yu; Andrew Futreal; Lindsey A Criswell; Jean H Tayar; Ramona Dadu; Vickie Shannon
Journal:  Cancer Immunol Immunother       Date:  2021-01-07       Impact factor: 6.968

Review 3.  Facts and Hopes in Prediction, Diagnosis, and Treatment of Immune-Related Adverse Events.

Authors:  James W Smithy; David M Faleck; Michael A Postow
Journal:  Clin Cancer Res       Date:  2022-04-01       Impact factor: 13.801

Review 4.  Immune Checkpoints and Innovative Therapies in Glioblastoma.

Authors:  Massimo Romani; Maria Pia Pistillo; Roberta Carosio; Anna Morabito; Barbara Banelli
Journal:  Front Oncol       Date:  2018-10-23       Impact factor: 6.244

Review 5.  The Road so Far in Colorectal Cancer Pharmacogenomics: Are We Closer to Individualised Treatment?

Authors:  Ana Rita Simões; Ceres Fernández-Rozadilla; Olalla Maroñas; Ángel Carracedo
Journal:  J Pers Med       Date:  2020-11-19

Review 6.  Pharmacogenetics of anticancer monoclonal antibodies.

Authors:  Dmitrii Shek; Scott A Read; Golo Ahlenstiel; Irina Piatkov
Journal:  Cancer Drug Resist       Date:  2019-03-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.